check_circleStudy Completed
Bacterial Infections
Bayer Identifier:
Trial_0570
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Ciprofloxacin oral suspension administered for 3 days versus ciprofloxacin oral suspension administered for 5 days in children and juveniles for the treatment of Shigella dysenteriae type one dysentery
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
253Trial Dates
May 1996 - June 2000Phase
Phase 3Could I Receive a placebo
N/AProducts
Cipro (Ciprofloxacin, BAYQ3939)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A